NASDAQ:AGLE
Aeglea BioTherapeutics, Inc.
- Stock
Last Close
11.26
27/11 21:00
Market Cap
48.63M
Beta: 1.76
Volume Today
43.24K
Avg: 725.60K
PE Ratio
−0.18
PFCF: −0.56
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -10.35M - | -11.29M 9.16% | -21.70M 92.10% | -27.24M 25.52% | -44.35M 62.83% | -78.25M 76.45% | -80.89M 3.37% | -65.80M 18.66% | -83.81M 27.38% | |
depreciation and amortization | 19K - | 89K 368.42% | 132K 48.31% | 249K 88.64% | 293K 17.67% | 418K 42.66% | 996K 138.28% | 1.58M 58.23% | 1.57M 0.57% | |
deferred income tax | 1.44M - | 4K 99.72% | -45K 1,225% | 84K 286.67% | 314K 273.81% | -314K 200% | -213K 32.17% | 204K 195.77% | ||
stock based compensation | 147K - | 767K 421.77% | 1.22M 59.19% | 2.49M 104.10% | 4.28M 71.75% | 4.88M 13.93% | 6.26M 28.30% | 8.04M 28.48% | 7.11M 11.53% | |
change in working capital | 26K - | -1.34M 5,253.85% | 1.45M 208.21% | -198K 113.66% | 7.20M 3,736.87% | 7.10M 1.35% | -2.54M 135.75% | 1.83M 172.17% | -5.50M 400.22% | |
accounts receivables | 3.08M - | |||||||||
inventory | 3.90M - | |||||||||
accounts payables | 102K - | -169K 265.69% | -8K 95.27% | 164K 2,150% | 239K 45.73% | 2.58M 980.75% | -544K 121.06% | 1.06M 295.77% | -2.64M 347.98% | |
other working capital | -76K - | -1.17M 1,440.79% | 1.46M 224.51% | -362K 124.83% | -20K 94.48% | 4.52M 22,705% | -2.00M 144.15% | 768K 138.48% | -2.86M 472.66% | |
other non cash items | 2.82M - | 797K 71.74% | 55K 93.10% | 78K 41.82% | 67K 14.10% | 478K 613.43% | 619K 29.50% | 434K 29.89% | 496K 14.29% | |
net cash provided by operating activities | -7.33M - | -10.98M 49.72% | -18.84M 71.55% | -24.61M 30.65% | -32.19M 30.79% | -65.69M 104.06% | -75.78M 15.35% | -53.72M 29.11% | -80.14M 49.20% | |
investments in property plant and equipment | -181K - | -208K 14.92% | -212K 1.92% | -619K 191.98% | -422K 31.83% | -1.49M 253.55% | -4.28M 186.86% | -573K 86.61% | -38K 93.37% | |
acquisitions net | 907K - | 504K 44.43% | -286K 156.75% | -344K 20.28% | 428K 224.42% | |||||
purchases of investments | -3.77M - | -20.39M 441.42% | -64.11M 214.44% | -62.18M 3.02% | -91.93M 47.84% | -129M 40.33% | -133.08M 3.16% | -39.50M 70.32% | ||
sales maturities of investments | 8.45M - | 42.20M 399.70% | 47.37M 12.24% | 91.68M 93.54% | 125.68M 37.08% | 111.03M 11.65% | 96.55M 13.05% | |||
other investing activites | -40K - | -40K 0% | 80K 300% | -907K - | -504K 44.43% | 286K 156.75% | 344K 20.28% | -428K 224.42% | ||
net cash used for investing activites | -221K - | -4.01M 1,716.29% | -12.08M 200.85% | -22.53M 86.56% | -15.23M 32.39% | -1.74M 88.58% | -7.60M 337.26% | -22.62M 197.46% | 57.01M 352.04% | |
debt repayment | -25K - | -20K 20% | -510K 2,450% | -418K 18.04% | ||||||
common stock issued | 5.58M - | 43.70M 683.89% | 49.29M 12.80% | 11.38M 76.91% | 54.05M 374.94% | 64.30M 18.96% | 153.72M 139.07% | 42.87M - | ||
common stock repurchased | ||||||||||
dividends paid | ||||||||||
other financing activites | -2.03M - | 76K 103.75% | 833K 996.05% | 3.02M 262.55% | 1.45M 51.99% | 816K 43.72% | 1.90M 133.21% | 222K 88.33% | ||
net cash used provided by financing activities | 5.58M - | 41.67M 647.52% | 49.37M 18.47% | 12.21M 75.26% | 57.07M 367.27% | 65.72M 15.17% | 154.51M 135.10% | 1.39M 99.10% | 42.68M 2,963.75% | |
effect of forex changes on cash | 51K - | -15K 129.41% | -106K 606.67% | |||||||
net change in cash | -1.98M - | 26.68M 1,446.69% | 18.45M 30.83% | -34.93M 289.29% | 9.64M 127.61% | -1.71M 117.71% | 71.18M 4,267.68% | -74.96M 205.30% | 19.44M 125.93% | |
cash at beginning of period | 4.60M - | 2.62M 43.09% | 29.29M 1,019.80% | 47.75M 63.00% | 12.82M 73.16% | 22.46M 75.24% | 20.75M 7.60% | 91.94M 343.01% | 16.98M 81.53% | |
cash at end of period | 2.62M - | 29.29M 1,019.80% | 47.75M 63.00% | 12.82M 73.16% | 22.46M 75.24% | 20.75M 7.60% | 91.94M 343.01% | 16.98M 81.53% | 36.42M 114.46% | |
operating cash flow | -7.33M - | -10.98M 49.72% | -18.84M 71.55% | -24.61M 30.65% | -32.19M 30.79% | -65.69M 104.06% | -75.78M 15.35% | -53.72M 29.11% | -80.14M 49.20% | |
capital expenditure | -181K - | -208K 14.92% | -212K 1.92% | -619K 191.98% | -422K 31.83% | -1.49M 253.55% | -4.28M 186.86% | -573K 86.61% | -38K 93.37% | |
free cash flow | -7.52M - | -11.19M 48.88% | -19.05M 70.26% | -25.23M 32.45% | -32.62M 29.25% | -67.18M 105.99% | -80.06M 19.16% | -54.29M 32.19% | -80.18M 47.69% |
All numbers in USD (except ratios and percentages)